Shingles Vaccines: What You Need to Know

Wednesday, December 06, 2017 at 12 PM ET

In the US, an estimated 1 out of 3 individuals will develop shingles, also known as herpes zoster, in their lifetime. Join Edward A. Belongia, MD, Director of the Center for Clinical Epidemiology & Population Health at the Marshfield Clinic Research Institute in Marshfield, WI, and Michael D. Hogue, PharmD, Professor of Pharmacy at the McWhorter School of Pharmacy and Associate Dean at the Samford University Center for Faith and Health in Birmingham, AL, for a discussion on the epidemiology of herpes zoster, current Advisory Committee on Immunization Practices (ACIP) recommendations regarding the use of shingles vaccines, and strategies to increase vaccination rates in older adults.

At the conclusion of this activity, participants will be able to:
-Describe the epidemiology and burden of disease of shingles in adults
-Discuss ACIP recommendations for use of zoster vaccines in adults
-Understand the scientific evidence used by ACIP in making its recommendations for zoster vaccination of adults
-Describe vaccine storage and handling, dosing,and administration for FDA-approved zoster vaccines
-Identify strategies for implementation of ACIP recommendations into practice

Continuing Medical Education (CME)
NFID is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NFID designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education (CNE)
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (OBN-001-91). It has been approved for a maximum of 1.0 contact hour.